SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-035008
Filing Date
2022-06-08
Accepted
2022-06-08 16:05:49
Documents
1
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4149
  Complete submission text file 0001209191-22-035008.txt   5601
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Issuer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ORCHARD THERAPEUTICS PLC 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address
Dunoyer Marc (Reporting) CIK: 0001793975 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38722 | Film No.: 221003538